The serum nitric oxide levels in patients with Duchenne muscular dystrophy

Gucuyener K., Ergenekon E., Erbas D., PINARLI F. G., Serdaroglu A.

BRAIN & DEVELOPMENT, cilt.22, sa.3, ss.181-183, 2000 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2000
  • Doi Numarası: 10.1016/s0387-7604(00)00106-6
  • Dergi Adı: BRAIN & DEVELOPMENT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.181-183
  • Gazi Üniversitesi Adresli: Evet

Özet

Nitric oxide is formed in skeletal muscle by the neuronal type nitric oxide synthase and the signalling function of dystrophin and related compounds are in part mediated by nitric oxide. Duchenne muscular dystrophy, mdx mice and patients with Becker dystrophy demonstrated neuronal type nitric oxide synthase deficiency in muscle biopsy specimens. We have intended to find out whether the plasma nitric oxide levels show any abnormality in patients with Duchenne muscular dystrophy. Serum NO levels of Duchenne patients (4.191 +/- 2.82 mu mol/l) were significantly lower than those of the control (39.53 +/- 19.43 mu mol/l) and cerebral palsy (77.84 +/- 21.70 mu mol/l) groups. (C) 2000 Elsevier Science B.V. All rights reserved.